| Entry |
|
|---|
| Name |
Tramazoline hydrochloride (JAN/USAN);
Towk (TN)
|
|---|
| Formula |
C13H17N3. HCl
|
|---|
| Exact mass |
251.1189
|
|---|
| Mol weight |
251.7551
|
|---|
| Structure |
     |
|---|
| Activity |
Adrenergic
|
|---|
| Remark |
Therapeutic category: ATC code: |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
132 Otic and nasal agents
1324 Otolaryngologic vasoconstrictors
D01347 Tramazoline hydrochloride (JAN/USAN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AA Sympathomimetics, plain
R01AA09 Tramazoline
D01347 Tramazoline hydrochloride (JAN/USAN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
alpha1-adrenergic receptor [HSA:146 147 148] [KO:K04137 K04136 K04135]
Tramazoline [ATC:R01AA09]
D01347 Tramazoline hydrochloride (JAN/USAN)
 |
|---|
| Other DBs |
CAS: 3715-90-0 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 17
1 C8x C 22.2840 -15.4841
2 C8y C 22.2840 -16.8854
3 C8x C 24.7100 -15.4841
4 C8x C 23.5006 -14.7834
5 C8y C 24.7100 -16.8854
6 C8y C 23.4972 -17.5801
7 C1x C 23.4924 -18.9777
8 C1x C 24.7004 -19.6808
9 C1x C 25.9132 -18.9861
10 C1x C 25.9180 -17.5883
11 N1b N 21.0718 -17.5881
12 C2y C 21.0741 -18.9895
13 N1x N 19.9410 -19.8172
14 C1x C 20.3764 -21.1494
15 C1x C 21.7777 -21.1466
16 N2x N 22.2085 -19.8133
17 X Cl 29.8639 -18.4566
BOND 18
1 5 6 2
2 6 7 1
3 7 8 1
4 8 9 1
5 9 10 1
6 10 5 1
7 4 1 1
8 2 11 1
9 11 12 1
10 1 2 2
11 2 6 1
12 5 3 1
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 16 12 2
18 3 4 2
|
|---|
